Brief: Medexus Announces Resubmission Of Treosulfan NDA

Medexus Pharmaceuticals

22/04/2022 13:47

April 22 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS PHARMACEUTICALS ANNOUNCES RESUBMISSION OF
TREOSULFAN NDA
    * MEDEXUS PHARMACEUTICALS INC - ADDITIONAL DATA COLLECTION
AND
ANALYSIS RECONFIRMS CONFIDENCE IN NEW DRUG APPLICATION FOR
TREOSULFAN
    * MEDEXUS PHARMACEUTICALS INC - NDA RESUBMISSION DATE
CONSISTENT
WITH PREVIOUSLY ANNOUNCED TIMELINE
    * MEDEXUS PHARMACEUTICALS INC - FDA DECISION STILL EXPECTED
WITHIN
SIX MONTHS OF RESUBMISSION

Source text for Eikon:  ID:nGNX43DRsB 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))